Glyburide 2.5 mg Tablets — Generic For Diabeta — TEVA

Medication Summary

Medication Summary: This section summarizes DailyMed drug label information to make the label easier to understand. It is not a substitute for the official label, pharmacist counseling, prescriber instructions, or medical advice.

Overview

Glyburide tablets are a prescription oral medicine in the sulfonylurea class. They are used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.

The tablets come in 1.25 mg, 2.5 mg, and 5 mg strengths. The label says glyburide works by stimulating the release of insulin from the pancreas, and that blood sugar lowering can persist with ongoing use. It also notes that some people may become less responsive over time.

Important safety information in the label includes a risk of severe low blood sugar, especially in certain higher-risk patients or when used with some other medicines. The product is not for type 1 diabetes, diabetic ketoacidosis, or use with bosentan.

Storage Information

Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in tight, light-resistant container as defined in the USP, with a child-resistant closure (as required).

Key Counseling Points

• Take glyburide with breakfast or the first main meal, unless your prescriber gives different directions.
• Follow the prescribed diet and exercise plan; the label says glyburide is used in addition to diet and exercise, not as a replacement.
• Watch for signs of low blood sugar, which can be severe with sulfonylureas like glyburide.
• Tell your healthcare professional about all medicines you take, since some drugs may increase or decrease glyburideu2019s effects.
• If you are switched from another diabetes medicine, the label says dosing may need to be retitrated.
• Blood sugar monitoring with urine and/or blood tests is important; the label also mentions glycosylated hemoglobin may be helpful in some patients.
• Report unusual symptoms such as skin reactions, yellowing of the skin or eyes, or persistent gastrointestinal upset.
• Do not use glyburide for type 1 diabetes or diabetic ketoacidosis, as listed in the label contraindications.
• The label advises keeping all medications out of the reach of children.

Helpful Patient Education

Glyburide tablets USP are a prescription sulfonylurea medicine used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. This product is available in 1.25 mg, 2.5 mg, and 5 mg strengths.

DailyMed labeling for glyburide also highlights important safety considerations, including the risk of hypoglycemia, the need for glucose monitoring, and several drug interaction warnings. This educational summary is based on the product’s official label information.

Medication Summary last generated: 2026-07-18 02:48:56